Anti-depressant Paroxetine Linked to Breast Cancer Deaths

February 9, 2010 /EIN PRESSWIRE/ Researchers at the University of Toronto have found that breast cancer patients taking the anti-depressant paroxetine at the same as tamoxifen, a drug for breast cancer recovery, are more likely to die from the disease.

According to the Mail Online, paroxetine, sold under the brand names Paxil and Seroxat, interferes with the effects of tamoxifen.

A spokesman for GlaxoSmithKline, the maker of the Paxil and Seroxat, said the company had updated warnings on the labels of the drugs in 2008.

Read more about this story at Breast Cancer News Today:

Latest Tamoxifen & Breast Cancer news –
Latest Anti-depressants & Breast Cancer news –

Located at, Breast Cancer News Today is a service of EIN News, an industry leader in news monitoring for business professionals and analysts. Using a combination of proprietary search technology and human editing, EIN News delivers to its members the latest breast cancer news from around the world, saving them valuable time they’d spend searching for information. New users to Breast Cancer News Today can enjoy a no-obligation, one-week free trial.

About EIN Presswire
The EIN Presswire press release distribution service is a news-syndication solution that distributes news to more than 10 million visitors annually at EIN News and millions more through its press release distribution partners. A news source for leading journalists, decision-makers and industry professionals worldwide, EIN Presswire targets press releases to a wide array of worldwide business professionals in more than 80 different industries. EIN Presswire also offers affiliate network opportunities and news distribution to tens of thousands of news subscribers daily. Read the newest business news at and the latest world news in more than 80 different industries at